Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients.

Arnaud Beddok,Alexandre Arsene-Henry,Baptiste Porte,Kim Cao,Nathaniel Scher,Joelle Otz,Mathieu Minsat,François-Clément Bidard,Alain Fourquet,Paul Cottu,Youlia M. Kirova

Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients.

2020

Arnaud Beddok
Alexandre Arsene-Henry
Baptiste Porte
Kim Cao
Nathaniel Scher
Joelle Otz
Mathieu Minsat
François-Clément Bidard
Alain Fourquet
Paul Cottu
Youlia M. Kirova

e12598Background: Palbociclib, a small-molecule inhibitor of cyclin-dependent kinases (CDK4 and CDK6), combined with letrozole increases progression-free survival among patients with previously unt...

Keywords:

CDK inhibitor
Oncology
Internal medicine
Medicine
Radiation therapy
Metastatic breast cancer
Pathology
Kinase
Palbociclib
Cyclin-dependent kinase 6
Letrozole

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations